These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 20465609)

  • 1. Vitiligo in an urban academic setting.
    Paravar T; Lee DJ
    Int J Dermatol; 2010 Jan; 49(1):39-43. PubMed ID: 20465609
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Profile of vitiligo patients attending a training and research hospital in Central Anatolia: a retrospective study.
    Gönül M; Cakmak SK; Oğuz D; Gül U; Kiliç S
    J Dermatol; 2012 Feb; 39(2):156-9. PubMed ID: 21955223
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Anti-thyroid peroxidase antibody and vitiligo: a controlled study.
    Daneshpazhooh M; Mostofizadeh G M; Behjati J; Akhyani M; Robati RM
    BMC Dermatol; 2006 Mar; 6():3. PubMed ID: 16526964
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Relevance of autoimmune thyroiditis in children and adolescents with vitiligo.
    Uncu S; Yaylı S; Bahadır S; Okten A; Alpay K
    Int J Dermatol; 2011 Feb; 50(2):175-9. PubMed ID: 21244381
    [TBL] [Abstract][Full Text] [Related]  

  • 5. An approach to the correlation between vitiligo and autoimmune thyroiditis in Chinese children.
    Yang Y; Lin X; Fu W; Luo X; Kang K
    Clin Exp Dermatol; 2010 Oct; 35(7):706-10. PubMed ID: 19874359
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Childhood- and later-onset vitiligo have diverse epidemiologic and clinical characteristics.
    Nicolaidou E; Antoniou C; Miniati A; Lagogianni E; Matekovits A; Stratigos A; Katsambas A
    J Am Acad Dermatol; 2012 Jun; 66(6):954-8. PubMed ID: 21982634
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prevalence of autoimmune thyroid disease and thyroid dysfunction in young Brazilian patients with type 1 diabetes.
    Araujo J; Brandão LA; Guimarães RL; Santos S; Falcão EA; Milanese M; Segat L; Souza PR; de Lima-Filho JL; Crovella S
    Pediatr Diabetes; 2008 Jul; 9(4 Pt 1):272-6. PubMed ID: 18466214
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of age of onset on disease characteristics in non-segmental vitiligo.
    Solak B; Dikicier BS; Cosansu NC; Erdem T
    Int J Dermatol; 2017 Mar; 56(3):341-345. PubMed ID: 28054375
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Late onset vitiligo: a study of 182 patients.
    Dogra S; Parsad D; Handa S; Kanwar AJ
    Int J Dermatol; 2005 Mar; 44(3):193-6. PubMed ID: 15807724
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Profile of childhood vitiligo in China: an analysis of 541 patients.
    Hu Z; Liu JB; Ma SS; Yang S; Zhang XJ
    Pediatr Dermatol; 2006; 23(2):114-6. PubMed ID: 16650215
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Skin findings in thyroid diseases.
    Artantaş S; Gül U; Kiliç A; Güler S
    Eur J Intern Med; 2009 Mar; 20(2):158-61. PubMed ID: 19327604
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Vitiligo presentation in adults.
    Mason CP; Gawkrodger DJ
    Clin Exp Dermatol; 2005 Jul; 30(4):344-5. PubMed ID: 15953063
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Vitiligo-epidemiological study of 4134 patients at the National Center for Vitiligo and Psoriasis in Central Saudi Arabia.
    Alissa A; Al Eisa A; Huma R; Mulekar S
    Saudi Med J; 2011 Dec; 32(12):1291-6. PubMed ID: 22159386
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Circulating autoantibodies and autoimmune comorbidities in vitiligo patients: a multicenter Italian study.
    Ingordo V; Cazzaniga S; Raone B; Digiuseppe MD; Musumeci ML; Fai D; Pellegrino M; Pezzarossa E; Di Lernia V; Battarra VC; Sirna R; Patrizi A; Naldi L
    Dermatology; 2014; 228(3):240-9. PubMed ID: 24603479
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Childhood vitiligo: a prospective hospital-based study.
    Al-Mutairi N; Sharma AK; Al-Sheltawy M; Nour-Eldin O
    Australas J Dermatol; 2005 Aug; 46(3):150-3. PubMed ID: 16008644
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comorbidities associated with vitiligo: a ten-year retrospective study.
    Sheth VM; Guo Y; Qureshi AA
    Dermatology; 2013; 227(4):311-5. PubMed ID: 24107643
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Epidemiological and clinical profile of vitiligo in Tunisia: retrospective study of 503 cases].
    Zeglaoui F; Souissi A; Ben Ayed A; Fazaa B; Kamoun MR
    Tunis Med; 2007 Dec; 85(12):1016-9. PubMed ID: 19170379
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical and immunological studies in vitiligo in the United Arab Emirates.
    Galadari I; Bener A; Hadi S; Lestringant GG
    Allerg Immunol (Paris); 1997 Dec; 29(10):297-9. PubMed ID: 9479431
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Vitiligo and associated autoimmune disease: retrospective review of 300 patients.
    Sawicki J; Siddha S; Rosen C
    J Cutan Med Surg; 2012; 16(4):261-6. PubMed ID: 22784519
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Profile of vitiligo in the south of Tunisia.
    Akrem J; Baroudi A; Aichi T; Houch F; Hamdaoui MH
    Int J Dermatol; 2008 Jul; 47(7):670-4. PubMed ID: 18613871
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.